• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

Mohs first line of therapy for non-melanoma eyelid tumors

Article

Wailea, Hawaii - After reviewing more than 100 previous studies regarding different modalities for treating non-melanoma eyelid tumors, the evidence-based results clearly point to Mohs micrographic surgery as the formidable first line of therapy, according to Harry H. Sharata, M.D., Ph.D.

Related Videos
Related Content
Secukinumab Demonstrates Promise for Patients With Severe Hidradenitis Suppurativa Who Found Adalimumab Intolerable

Secukinumab Demonstrates Promise for Patients With Severe Hidradenitis Suppurativa Who Found Adalimumab Intolerable

Article
The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment

The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment

Podcast
FDA Issues Alert on Counterfeit Botox: What Dermatology Clinicians Need to Know

FDA Issues Alert on Counterfeit Botox: What Dermatology Clinicians Need to Know

Article
ReV Up Your Vitiligo Treatment Strategies

ReV Up Your Vitiligo Treatment Strategies

Podcast
Reviewing the Rosacea Pipeline: A Look at the Last 10 Years

Reviewing the Rosacea Pipeline: A Look at the Last 10 Years

Article
Is Your Texting as Caring as Your Bedside Manner?

Is Your Texting as Caring as Your Bedside Manner?

Article
© 2024 MJH Life Sciences

All rights reserved.